{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:13:45Z","timestamp":1792782825386,"version":"4.5.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2016,4,26]],"date-time":"2016-04-26T00:00:00Z","timestamp":1461628800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"The Committee of Science and Technology of Shanghai.","award":["13JC140680"],"award-info":[{"award-number":["13JC140680"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["91232716"],"award-info":[{"award-number":["91232716"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Ministry of Science and Technology of China","award":["2015CB553500"],"award-info":[{"award-number":["2015CB553500"]}],"id":[{"id":"https:\/\/ror.org\/02kv4zf79","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1007\/s00213-016-4292-z","type":"journal-article","created":{"date-parts":[[2016,4,25]],"date-time":"2016-04-25T19:44:35Z","timestamp":1461613475000},"page":"2411-2418","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The anxiolytic- and antidepressant-like effects of ATPM-ET, a novel \u03ba agonist and \u03bc partial agonist, in mice"],"prefix":"10.1007","volume":"233","author":[{"given":"Qian","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Hang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gui-Ying","family":"Zan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Hong","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing-Gen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,26]]},"reference":[{"key":"4292_CR1","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1007\/BF02532378","volume":"21","author":"S Archer","year":"1996","unstructured":"Archer S, Glick SD, Bidlack JM (1996) Cyclazocine revisited. Neurochem Res 21:1369\u20131373","journal-title":"Neurochem Res"},{"key":"4292_CR2","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pbb.2013.01.023","volume":"105","author":"A Bahi","year":"2013","unstructured":"Bahi A (2013) Individual differences in elevated plus-maze exploration predicted higher ethanol consumption and preference in outbred mice. Pharmacol Biochem Behav 105:83\u201388","journal-title":"Pharmacol Biochem Behav"},{"key":"4292_CR3","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00213-005-0167-4","volume":"183","author":"PM Beardsley","year":"2005","unstructured":"Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183:118\u2013126","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1017\/S1461145711001842","volume":"16","author":"E Berrocoso","year":"2013","unstructured":"Berrocoso E, Ikeda K, Sora I, Uhl GR, Sanchez-Blazquez P, Mico JA (2013) Active behaviours produced by antidepressants and opioids in the mouse tail suspension test. Int J Neuropsychopharmacol 16:151\u2013162","journal-title":"Int J Neuropsychopharmacol"},{"key":"4292_CR5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/00004714-199502000-00008","volume":"15","author":"JA Bodkin","year":"1995","unstructured":"Bodkin JA, Zornberg GL, Lukas SE, Cole JO (1995) Buprenorphine treatment of refractory depression. J Clin Psychopharmacol 15:49\u201357","journal-title":"J Clin Psychopharmacol"},{"key":"4292_CR6","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/j.1476-5381.2009.00230.x","volume":"157","author":"D Braida","year":"2009","unstructured":"Braida D, Capurro V, Zani A, Rubino T, Vigano D, Parolaro D, Sala M (2009) Potential anxiolytic- and antidepressant-like effects of salvinorin A, the main active ingredient of Salvia divinorum, in rodents. Br J Pharmacol 157:844\u2013853","journal-title":"Br J Pharmacol"},{"key":"4292_CR7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0008528","volume":"4","author":"MR Bruchas","year":"2009","unstructured":"Bruchas MR, Land BB, Lemos JC, Chavkin C (2009) CRF1-R activation of the dynorphin\/kappa opioid system in the mouse basolateral amygdala mediates anxiety-like behavior. PLoS One 4, e8528. doi: 10.1371\/journal.pone.0008528","journal-title":"PLoS One"},{"key":"4292_CR8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.brainres.2009.08.062","volume":"1314","author":"MR Bruchas","year":"2010","unstructured":"Bruchas MR, Land BB, Chavkin C (2010) The dynorphin\/kappa opioid system as a modulator of stress-induced and pro-addictive behaviors. Brain Res 1314:44\u201355","journal-title":"Brain Res"},{"key":"4292_CR9","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1124\/jpet.105.092304","volume":"316","author":"WA Carlezon Jr","year":"2006","unstructured":"Carlezon WA Jr, Beguin C, DiNieri JA, Baumann MH, Richards MR, Todtenkopf MS, Rothman RB, Ma Z, Lee DY, Cohen BM (2006) Depressive-like effects of the kappa-opioid receptor agonist salvinorin A on behavior and neurochemistry in rats. J Pharmacol Exp Ther 316:440\u2013447","journal-title":"J Pharmacol Exp Ther"},{"key":"4292_CR10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","volume":"210","author":"GV Carr","year":"2010","unstructured":"Carr GV, Lucki I (2010) Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats. Psychopharmacology (Berl) 210:295\u2013302","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/sj.npp.1300433","volume":"29","author":"SC Dulawa","year":"2004","unstructured":"Dulawa SC, Holick KA, Gundersen B, Hen R (2004) Effects of chronic fluoxetine in animal models of anxiety and depression. Neuropsychopharmacology 29:1321\u20131330","journal-title":"Neuropsychopharmacology"},{"key":"4292_CR12","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","volume":"232","author":"E Falcon","year":"2015","unstructured":"Falcon E, Maier K, Robinson SA, Hill-Smith TE, Lucki I (2015) Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice. Psychopharmacology (Berl) 232:907\u2013915","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR13","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/0269881110367724","volume":"25","author":"T Femen\u00eda","year":"2011","unstructured":"Femen\u00eda T, Perez-Rial S, Uriguen L, Manzanares J (2011) Prodynorphin gene deletion increased anxiety-like behaviours, impaired the anxiolytic effect of bromazepam and altered GABAA receptor subunits gene expression in the amygdala. J Psychopharmacol 25:87\u201396","journal-title":"J Psychopharmacol"},{"key":"4292_CR14","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","volume":"25","author":"D Filliol","year":"2000","unstructured":"Filliol D, Ghozland S, Chluba J, Martin M, Matthes HW, Simonin F, Befort K, Gaveriaux-Ruff C, Dierich A, LeMeur M, Valverde O, Maldonado R, Kieffer BL (2000) Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses. Nat Genet 25:195\u2013200","journal-title":"Nat Genet"},{"key":"4292_CR15","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s00213-008-1112-0","volume":"198","author":"EM Glover","year":"2008","unstructured":"Glover EM, Davis M (2008) Anxiolytic-like effects of morphine and buprenorphine in the rat model of fear-potentiated startle: tolerance, cross-tolerance, and blockade by naloxone. Psychopharmacology (Berl) 198:167\u2013180","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR16","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejphar.2014.04.008","volume":"735","author":"D Gupta","year":"2014","unstructured":"Gupta D, Radhakrishnan M, Thangaraj D, Kurhe Y (2014) Antidepressant and anti-anxiety like effects of 4i (N-(3-chloro-2-methylphenyl) quinoxalin-2-carboxamide), a novel 5-HT3 receptor antagonist in acute and chronic neurobehavioral rodent models. Eur J Pharmacol 735:59\u201367","journal-title":"Eur J Pharmacol"},{"key":"4292_CR17","doi-asserted-by":"crossref","first-page":"103","DOI":"10.4103\/0975-7406.154429","volume":"7","author":"D Gupta","year":"2015","unstructured":"Gupta D, Radhakrishnan M, Thangaraj D, Kurhe Y (2015) Pharmacological evaluation of novel 5-HT3 receptor antagonist, QCM-13 (N-cyclohexyl-3-methoxyquinoxalin-2-carboxamide) as anti-anxiety agent in behavioral test battery. J Pharm Bioallied Sci 7:103\u2013108","journal-title":"J Pharm Bioallied Sci"},{"key":"4292_CR18","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/aps.2015.32","volume":"36","author":"A Hang","year":"2015","unstructured":"Hang A, Wang YJ, He L, Liu JG (2015) The role of the dynorphin\/kappa opioid receptor system in anxiety. Acta Pharmacol Sin 36:783\u2013790","journal-title":"Acta Pharmacol Sin"},{"key":"4292_CR19","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00213-005-0138-9","volume":"182","author":"EM Jutkiewicz","year":"2005","unstructured":"Jutkiewicz EM, Rice KC, Traynor JR, Woods JH (2005) Separation of the convulsions and antidepressant-like effects produced by the delta-opioid agonist SNC80 in rats. Psychopharmacology (Berl) 182:588\u2013596","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR20","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejphar.2005.12.002","volume":"531","author":"EM Jutkiewicz","year":"2006","unstructured":"Jutkiewicz EM, Torregrossa MM, Sobczyk-Kojiro K, Mosberg HI, Folk JE, Rice KC, Watson SJ, Woods JH (2006) Behavioral and neurobiological effects of the enkephalinase inhibitor RB101 relative to its antidepressant effects. Eur J Pharmacol 531:151\u2013159","journal-title":"Eur J Pharmacol"},{"key":"4292_CR21","doi-asserted-by":"crossref","first-page":"785","DOI":"10.4088\/JCP.13m08725","volume":"75","author":"JF Karp","year":"2014","unstructured":"Karp JF, Butters MA, Begley AE, Miller MD, Lenze EJ, Blumberger DM, Mulsant BH, Reynolds CF 3rd (2014) Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults. J Clin Psychiatry 75:785\u2013793","journal-title":"J Clin Psychiatry"},{"key":"4292_CR22","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.brainres.2009.09.074","volume":"1314","author":"AT Knoll","year":"2010","unstructured":"Knoll AT, Carlezon WA Jr (2010) Dynorphin, stress, and depression. Brain Res 1314:56\u201373","journal-title":"Brain Res"},{"key":"4292_CR23","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1124\/jpet.107.127415","volume":"323","author":"AT Knoll","year":"2007","unstructured":"Knoll AT, Meloni EG, Thomas JB, Carroll FI, Carlezon WA Jr (2007) Anxiolytic-like effects of kappa-opioid receptor antagonists in models of unlearned and learned fear in rats. J Pharmacol Exp Ther 323:838\u2013845","journal-title":"J Pharmacol Exp Ther"},{"key":"4292_CR24","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.biopsych.2011.03.017","volume":"70","author":"AT Knoll","year":"2011","unstructured":"Knoll AT, Muschamp JW, Sillivan SE, Ferguson D, Dietz DM, Meloni EG, Carroll FI, Nestler EJ, Konradi C, Carlezon WA Jr (2011) Kappa opioid receptor signaling in the basolateral amygdala regulates conditioned fear and anxiety in rats. Biol Psychiatry 70:425\u2013433","journal-title":"Biol Psychiatry"},{"key":"4292_CR25","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.ejphar.2015.06.030","volume":"762","author":"N Kordjazy","year":"2015","unstructured":"Kordjazy N, Haj-Mirzaian A, Amiri S, Ostadhadi S, Kordjazy M, Sharifzadeh M, Dehpour AR (2015) Elevated level of nitric oxide mediates the anti-depressant effect of rubidium chloride in mice. Eur J Pharmacol 762:411\u2013418","journal-title":"Eur J Pharmacol"},{"key":"4292_CR26","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/j.peptides.2004.05.005","volume":"25","author":"NN Kudryavtseva","year":"2004","unstructured":"Kudryavtseva NN, Gerrits MA, Avgustinovich DF, Tenditnik MV, Van Ree JM (2004) Modulation of anxiety-related behaviors by mu- and kappa-opioid receptor agonists depends on the social status of mice. Peptides 25:1355\u20131363","journal-title":"Peptides"},{"key":"4292_CR27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1007\/s10517-005-0479-8","volume":"140","author":"NN Kudryavtseva","year":"2005","unstructured":"Kudryavtseva NN, Gerrits MA, Alekseenko OV, Van Ree JM (2005) Chronic cocaine injections attenuate behavioral response of kappa-opioid receptors to U-50,488H agonist. Bull Exp Biol Med 140:320\u2013322","journal-title":"Bull Exp Biol Med"},{"key":"4292_CR28","doi-asserted-by":"crossref","first-page":"100","DOI":"10.4103\/0253-7613.125186","volume":"46","author":"YV Kurhe","year":"2014","unstructured":"Kurhe YV, Radhakrishnan M, Thangaraj D, Gupta D (2014) Anti-anxiety effect of a novel 5-HT(3) receptor antagonist N-(benzo[d]thiazol-2-yl)-3-ethoxyquinoxalin-2-carboxamide (6k) using battery tests for anxiety in mice. Indian J Pharmacol 46:100\u2013104","journal-title":"Indian J Pharmacol"},{"key":"4292_CR29","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/sj.npp.1300959","volume":"31","author":"A Kuzmin","year":"2006","unstructured":"Kuzmin A, Madjid N, Terenius L, Ogren SO, Bakalkin G (2006) Big dynorphin, a prodynorphin-derived peptide produces NMDA receptor-mediated effects on memory, anxiolytic-like and locomotor behavior in mice. Neuropsychopharmacology 31:1928\u20131937","journal-title":"Neuropsychopharmacology"},{"key":"4292_CR30","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.tins.2012.11.002","volume":"36","author":"PE Lutz","year":"2013","unstructured":"Lutz PE, Kieffer BL (2013) Opioid receptors: distinct roles in mood disorders. Trends Neurosci 36:195\u2013206","journal-title":"Trends Neurosci"},{"key":"4292_CR31","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","volume":"305","author":"SD Mague","year":"2003","unstructured":"Mague SD, Pliakas AM, Todtenkopf MS, Tomasiewicz HC, Zhang Y, Stevens WC Jr, Jones RM, Portoghese PS, Carlezon WA Jr (2003) Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats. J Pharmacol Exp Ther 305:323\u2013330","journal-title":"J Pharmacol Exp Ther"},{"key":"4292_CR32","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1186\/1472-6882-14-310","volume":"14","author":"M Mesfin","year":"2014","unstructured":"Mesfin M, Asres K, Shibeshi W (2014) Evaluation of anxiolytic activity of the essential oil of the aerial part of Foeniculum vulgare Miller in mice. BMC Complement Altern Med 14:310. doi: 10.1186\/1472-6882-14-310","journal-title":"BMC Complement Altern Med"},{"key":"4292_CR33","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ejphar.2007.03.031","volume":"566","author":"PS Naidu","year":"2007","unstructured":"Naidu PS, Lichtman AH, Archer CC, May EL, Harris LS, Aceto MD (2007) NIH 11082 produces anti-depressant-like activity in the mouse tail-suspension test through a delta-opioid receptor mechanism of action. Eur J Pharmacol 566:132\u2013136","journal-title":"Eur J Pharmacol"},{"key":"4292_CR34","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1097\/JCP.0b013e31818638a4","volume":"28","author":"PW Nyhuis","year":"2008","unstructured":"Nyhuis PW, Gastpar M, Scherbaum N (2008) Opiate treatment in depression refractory to antidepressants and electroconvulsive therapy. J Clin Psychopharmacol 28:593\u2013595. doi: 10.1097\/JCP.0b013e31818638a4","journal-title":"J Clin Psychopharmacol"},{"key":"4292_CR35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ejphar.2011.04.017","volume":"661","author":"MF Peters","year":"2011","unstructured":"Peters MF, Zacco A, Gordon J, Maciag CM, Litwin LC, Thompson C, Schroeder P, Sygowski LA, Piser TM, Brugel TA (2011) Identification of short-acting kappa-opioid receptor antagonists with anxiolytic-like activity. Eur J Pharmacol 661:27\u201334","journal-title":"Eur J Pharmacol"},{"key":"4292_CR36","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1126\/science.3016896","volume":"233","author":"A Pfeiffer","year":"1986","unstructured":"Pfeiffer A, Brantl V, Herz A, Emrich HM (1986) Psychotomimesis mediated by kappa opiate receptors. Science 233:774\u2013776","journal-title":"Science"},{"key":"4292_CR37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0049669","volume":"7","author":"B Rogala","year":"2012","unstructured":"Rogala B, Li Y, Li S, Chen X, Kirouac GJ (2012) Effects of a post-shock injection of the kappa opioid receptor antagonist norbinaltorphimine (norBNI) on fear and anxiety in rats. PLoS One 7, e49669. doi: 10.1371\/journal.pone.0049669","journal-title":"PLoS One"},{"key":"4292_CR38","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0024-3205(02)02220-8","volume":"72","author":"MO Rojas-Corrales","year":"2002","unstructured":"Rojas-Corrales MO, Berrocoso E, Gibert-Rahola J, Mico JA (2002) Antidepressant-like effects of tramadol and other central analgesics with activity on monoamines reuptake, in helpless rats. Life Sci 72:143\u2013152","journal-title":"Life Sci"},{"key":"4292_CR39","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","volume":"95","author":"A Saitoh","year":"2004","unstructured":"Saitoh A, Kimura Y, Suzuki T, Kawai K, Nagase H, Kamei J (2004) Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents. J Pharmacol Sci 95:374\u2013380","journal-title":"J Pharmacol Sci"},{"key":"4292_CR40","first-page":"563","volume":"75","author":"TS Shippenberg","year":"1986","unstructured":"Shippenberg TS, Herz A (1986) Differential effects of mu and kappa opioid systems on motivational processes. NIDA Res Monogr 75:563\u2013566","journal-title":"NIDA Res Monogr"},{"key":"4292_CR41","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","volume":"90","author":"Y Shirayama","year":"2004","unstructured":"Shirayama Y, Ishida H, Iwata M, Hazama GI, Kawahara R, Duman RS (2004) Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J Neurochem 90:1258\u20131268","journal-title":"J Neurochem"},{"key":"4292_CR42","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1523\/JNEUROSCI.2980-11.2012","volume":"32","author":"JS Smith","year":"2012","unstructured":"Smith JS, Schindler AG, Martinelli E, Gustin RM, Bruchas MR, Chavkin C (2012) Stress-induced activation of the dynorphin\/kappa-opioid receptor system in the amygdala potentiates nicotine conditioned place preference. J Neurosci 32:1488\u20131495","journal-title":"J Neurosci"},{"key":"4292_CR43","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/BF00428203","volume":"85","author":"L Steru","year":"1985","unstructured":"Steru L, Chermat R, Thierry B, Simon P (1985) The tail suspension test: a new method for screening antidepressants in mice. Psychopharmacology (Berl) 85:367\u2013370","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR44","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1038\/aps.2010.164","volume":"31","author":"JF Sun","year":"2010","unstructured":"Sun JF, Wang YH, Li FY, Lu G, Tao YM, Cheng Y, Chen J, Xu XJ, Chi ZQ, Neumeyer JL, Zhang A, Liu JG (2010) Effects of ATPM-ET, a novel kappa agonist with partial mu activity, on physical dependence and behavior sensitization in mice. Acta Pharmacol Sin 31:1547\u20131552","journal-title":"Acta Pharmacol Sin"},{"key":"4292_CR45","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ejphar.2014.06.045","volume":"740","author":"JF Sun","year":"2014","unstructured":"Sun JF, Wang YH, Chai JR, Li FY, Hang A, Lu G, Tao YM, Cheng Y, Chi ZQ, Neumeyer JL, Zhang A, Liu JG, Wang YJ (2014) Pharmacological characterization and therapeutic potential for the treatment of opioid abuse with ATPM-ET, an N-ethyl substituted aminothiazolomorphinan with kappa agonist and mu agonist\/antagonist activity. Eur J Pharmacol 740:455\u2013463","journal-title":"Eur J Pharmacol"},{"key":"4292_CR46","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0091-3057(95)00067-7","volume":"52","author":"P Tejedor-Real","year":"1995","unstructured":"Tejedor-Real P, Mico JA, Maldonado R, Roques BP, Gibert-Rahola J (1995) Implication of endogenous opioid system in the learned helplessness model of depression. Pharmacol Biochem Behav 52:145\u2013152","journal-title":"Pharmacol Biochem Behav"},{"key":"4292_CR47","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.pbb.2012.03.019","volume":"102","author":"GR Valdez","year":"2012","unstructured":"Valdez GR, Harshberger E (2012) kappa opioid regulation of anxiety-like behavior during acute ethanol withdrawal. Pharmacol Biochem Behav 102:44\u201347","journal-title":"Pharmacol Biochem Behav"},{"key":"4292_CR48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00213-013-3195-5","volume":"229","author":"A Veer Van\u2019t","year":"2013","unstructured":"Van\u2019t Veer A, Carlezon WA Jr (2013) Role of kappa-opioid receptors in stress and anxiety-related behavior. Psychopharmacology (Berl) 229:435\u2013452","journal-title":"Psychopharmacology (Berl)"},{"key":"4292_CR49","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.peptides.2007.10.012","volume":"29","author":"R Vergura","year":"2008","unstructured":"Vergura R, Balboni G, Spagnolo B, Gavioli E, Lambert DG, McDonald J, Trapella C, Lazarus LH, Regoli D, Guerrini R, Salvadori S, Calo G (2008) Anxiolytic- and antidepressant-like activities of H-Dmt-Tic-NH-CH(CH2-COOH)-Bid (UFP-512), a novel selective delta opioid receptor agonist. Peptides 29:93\u2013103","journal-title":"Peptides"},{"key":"4292_CR50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.pbb.2004.04.017","volume":"78","author":"MA Wilson","year":"2004","unstructured":"Wilson MA, Burghardt PR, Ford KA, Wilkinson MB, Primeaux SD (2004) Anxiolytic effects of diazepam and ethanol in two behavioral models: comparison of males and females. Pharmacol Biochem Behav 78:445\u2013458","journal-title":"Pharmacol Biochem Behav"},{"key":"4292_CR51","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/npp.2008.142","volume":"34","author":"W Wittmann","year":"2009","unstructured":"Wittmann W, Schunk E, Rosskothen I, Gaburro S, Singewald N, Herzog H, Schwarzer C (2009) Prodynorphin-derived peptides are critical modulators of anxiety and regulate neurochemistry and corticosterone. Neuropsychopharmacology 34:775\u2013785","journal-title":"Neuropsychopharmacology"},{"key":"4292_CR52","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/syn.20067","volume":"54","author":"JH Yoo","year":"2004","unstructured":"Yoo JH, Lee SY, Loh HH, Ho IK, Jang CG (2004) Altered emotional behaviors and the expression of 5-HT1A and M1 muscarinic receptors in micro-opioid receptor knockout mice. Synapse 54:72\u201382","journal-title":"Synapse"},{"key":"4292_CR53","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.bbr.2015.05.053","volume":"291","author":"GY Zan","year":"2015","unstructured":"Zan GY, Wang Q, Wang YJ, Liu Y, Hang A, Shu XH, Liu JG (2015) Antagonism of kappa opioid receptor in the nucleus accumbens prevents the depressive-like behaviors following prolonged morphine abstinence. Behav Brain Res 291:334\u2013341","journal-title":"Behav Brain Res"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4292-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-016-4292-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-016-4292-z","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T16:23:52Z","timestamp":1558628632000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-016-4292-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,26]]},"references-count":53,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["4292"],"URL":"https:\/\/doi.org\/10.1007\/s00213-016-4292-z","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,26]]}}}